Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
2007

DNA Methylation Markers for Lung Adenocarcinoma

Sample size: 51 publication Evidence: high

Author Information

Author(s): Tsou Jeffrey A, Galler Janice S, Siegmund Kimberly D, Laird Peter W, Turla Sally, Cozen Wendy, Hagen Jeffrey A, Koss Michael N, Laird-Offringa Ite A

Primary Institution: Keck School of Medicine, University of Southern California

Hypothesis

Can specific DNA methylation markers improve the early detection of lung adenocarcinoma?

Conclusion

The study identified eight significant DNA methylation markers for lung adenocarcinoma, with four showing high potential for early detection.

Supporting Evidence

  • Thirteen loci showed significant differential DNA methylation levels between tumor and non-tumor lung.
  • Four markers (CDKN2A EX2, CDX2, HOXA1, and OPCML) had a sensitivity of 67-86% and specificity of 74-82%.
  • Using a random forest classifier, a sensitivity of 94% and specificity of 90% was achieved with the top four markers.

Takeaway

Researchers found special markers in DNA that can help doctors spot lung cancer early, which is really important for saving lives.

Methodology

Real-time PCR-based method MethyLight was used to examine DNA methylation at twenty-eight loci in lung adenocarcinoma and control samples.

Potential Biases

Potential bias due to the limited diversity in the sample population.

Limitations

The study had a small sample size and may not represent all demographics.

Participant Demographics

28 males and 18 females, with a mix of racial/ethnic backgrounds including White, Black, and Asian.

Statistical Information

P-Value

p < 1 × 10-9

Statistical Significance

p < 0.0001

Digital Object Identifier (DOI)

10.1186/1476-4598-6-70

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication